Supplementary Table I (online only).
Bivariate analysis of patient's medications and status of deep venous thrombosis (DVT)
| Medications | In sample (n = 71) | DVT Negative (n = 37) | DVT Positive (n = 34) | P value |
|---|---|---|---|---|
| Aspirin | .315 | |||
| No | 47 (66.2) | 22 (59.46) | 25 (73.53) | |
| Yes | 24 (33.8) | 15 (40.54) | 9 (26.47) | |
| Angiotensin-converting enzyme inhibitor | .665 | |||
| No | 66 (92.96) | 35 (94.59) | 31 (91.18) | |
| Yes | 5 (7.04) | 2 (5.41) | 3 (8.82) | |
| Angiotensin receptor blockers | .599 | |||
| No | 67 (94.37) | 36 (97.3) | 31 (93.94) | |
| Yes | 3 (4.23) | 1 (2.7) | 2 (6.06) | |
| Missing | 1 (1.41) | |||
| Hydroxychloroquine | >.99 | |||
| No | 28 (39.44) | 15 (40.54) | 13 (38.24) | |
| Yes | 43 (60.56) | 22 (59.46) | 21 (61.76) | |
| Hypoglycemics | .315 | |||
| No | 46 (64.79) | 22 (59.46) | 24 (72.73) | |
| Yes | 24 (33.8) | 15 (40.54) | 9 (27.27) | |
| Missing | 1 (1.41) | |||
| Statins | >.99 | |||
| No | 50 (70.42) | 26 (70.27) | 24 (70.59) | |
| Yes | 21 (29.58) | 11 (29.73) | 10 (29.41) | |
| Antiviral medications | .479 | |||
| No | 61 (85.92) | 30 (83.33) | 31 (91.18) | |
| Yes | 9 (12.68) | 6 (16.67) | 3 (8.82) | |
| Missing | 1 (1.41) | |||
| Anticoagulation status at the time of diagnosis | >.99 | |||
| No | 1 (1.41) | 1 (2.7) | 0 (0) | |
| Yes | 70 (98.59) | 36 (97.3) | 34 (100) | |
| If yes, types | .515 | |||
| Therapeutic | 11 (15.71) | 7 (19.44) | 4 (11.76) | |
| Prophylactic | 59 (84.29) | 29 (80.56) | 30 (88.24) | |